Top Tweets for #ISRHT22

almost 4 years ago

How can new technologies aid #criticalcare of patients? Learn how tablets can be used to assess and study the treatment of acute #braininjury in our recent paper. Read more: https://t.co/RSoQkttl1l #ISRHT22 @Akademiska_Nytt @uppsalauni @evagaresp

drgalos's tweet photo. How can new technologies aid #criticalcare of patients? Learn how tablets can be used to assess and study the treatment of acute #braininjury in our recent paper.

Read more:
https://t.co/RSoQkttl1l

#ISRHT22 @Akademiska_Nytt @uppsalauni @evagaresp https://t.co/Mo9KZnocTx

Joel Lenell @joellenell

almost 4 years ago

The rationale behind GRACE v2.0 in long-term risk prediction after ACS appear weak. Items like HR and BP at presentation are likely of no long-term significance, while excluded measures like LVEF & NTproBNP are. An opportunity to improve prediction? #ISRHT22

Joel Lenell @joellenell

almost 4 years ago

@f2harrell When studying added prognostic value of a new variable to a model, is there any setting where you think the C-Statistic provide a better understanding than the LR-test with comparison of Chi2? https://t.co/94VVq0rMmu #ISRHT22

Joel Lenell @joellenell

almost 4 years ago

GLS proved to be an independent predictor of death & HF-hospitalization after ACS. The marginal improvement in Harrell’s C from GLS on top of LVEF and clinical data does however suggest a limited clinical application of GLS in this population. #ISRHT22 https://t.co/274v8F34CH

Joel Lenell @joellenell

almost 4 years ago

LVEF reported to the SWEDEHEART registry appears reliable. Discrimination between stages of reduced LVEF in clinical practice does however remain more challenging. Check out our SWEDEHEART validation study. #ISRHT22 https://t.co/Hq8Jo5gaxI

Top Tweets for #ISRHT22

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users